Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Children with familial hypercholesterolemia display changes in LDL and HDL function: a cross-sectional study

View ORCID ProfileJacob J. Christensen, View ORCID ProfileIngunn Narverud, View ORCID ProfileMaija Ruuth, View ORCID ProfileMartin Heier, View ORCID ProfileMatti Jauhiainen, View ORCID ProfileStine M. Ulven, View ORCID ProfileMartin P. Bogsrud, View ORCID ProfilePetri T. Kovanen, View ORCID ProfileBente Halvorsen, View ORCID ProfileMichael N. Oda, View ORCID ProfileCecilie Wium, View ORCID ProfileKjetil Retterstøl, View ORCID ProfileKatariina Öörni, View ORCID ProfileKirsten B. Holven
doi: https://doi.org/10.1101/2020.11.11.20214247
Jacob J. Christensen
1Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Forskningsveien 2B, 0373 Oslo, Norway
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob J. Christensen
  • For correspondence: j.j.christensen@medisin.uio.no
Ingunn Narverud
1Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Forskningsveien 2B, 0373 Oslo, Norway
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ingunn Narverud
Maija Ruuth
3Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland
4Research Programs Unit, Faculty of Medicine, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maija Ruuth
Martin Heier
5Pediatric Department, Oslo University Hospital Ullevaal, Oslo, Norway
6Oslo Diabetes Research Centre, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Heier
Matti Jauhiainen
7Minerva Foundation Institute for Medical Research and National Institute for Health and Welfare, Biomedicum 2U, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matti Jauhiainen
Stine M. Ulven
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stine M. Ulven
Martin P. Bogsrud
1Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Forskningsveien 2B, 0373 Oslo, Norway
8Unit for Cardiac and Cardiovascular Genetics, Oslo University Hospital, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin P. Bogsrud
Petri T. Kovanen
3Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Petri T. Kovanen
Bente Halvorsen
9Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, 0424 Oslo, Norway
10Faculty of Medicine, University of Oslo, 0424 Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bente Halvorsen
Michael N. Oda
11Seer BioLogics, Inc., Fairfield, CA, 94534, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael N. Oda
Cecilie Wium
12The Lipid Clinic, Oslo University Hospital, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cecilie Wium
Kjetil Retterstøl
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway
12The Lipid Clinic, Oslo University Hospital, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kjetil Retterstøl
Katariina Öörni
3Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland
13Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katariina Öörni
Kirsten B. Holven
1Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Forskningsveien 2B, 0373 Oslo, Norway
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kirsten B. Holven
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The functional status of lipoprotein particles contributes to atherogenesis. The tendency of plasma LDL particles to aggregate and the ability of HDL particles to induce and mediate reverse cholesterol transport associate with high and low risk for cardiovascular disease in adult patients, respectively. However, it is unknown whether children with familial hypercholesterolemia (FH) display lipoprotein function alterations.

Hypothesis We hypothesized that FH children had disrupted lipoprotein function.

Methods We analyzed LDL aggregation susceptibility and HDL-apoA-I exchange to apoA-I ratio (HAE/apoA-I ratio), and activity of four proteins that regulate lipoprotein metabolism (CETP, LCAT, PLTP and PON1) in plasma samples derived from children with FH (n = 47) and from healthy children (n = 56). Potential biological mechanisms behind any variation in lipoprotein functionalities were explored using an NMR-based metabolomics profiling approach.

Results LDL aggregation was higher and HAE/apoA-I ratio was lower in FH children than in healthy children. LDL aggregation associated positively with LDL-C and negatively with triglycerides, and HAE/apoA-I ratio associated negatively with LDL-C. Generally, the metabolomic profile for LDL aggregation was a mirror image of that for HAE/apoA-I ratio.

Conclusions FH children displayed increased atherogenicity of LDL and disrupted HDL function. These newly observed functional alterations in LDL and HDL may increase the risk for atherosclerotic cardiovascular disease in FH children.

Competing Interest Statement

Dr. Christensen has received research grants and/or personal fees from Mills DA, unrelated to the content of this manuscript. Drs. Ruuth, Kovanen and Oorni have applied for a patent on the LDL aggregation method; otherwise they have no other relevant financial relationships to disclose. Dr. Ulven has received research grants from Tine DA, Mills DA, and Olympic Seafood, none of which are related to the content of this manuscript. Dr. Retterstol reports personal fees from Amgen, Mills DA, The Norwegian Medical Association, The Norwegian Directorate of Health, Sanofi, Takeda, Chiesi, Bayer, MSD, and research grants from Oslo Economics and Mills outside the submitted work. Dr. Heier has received a research grant from the Norwegian Diabetes Association for analyses included in this manuscript. Dr. Holven has received research grants and/or personal fees from Tine DA, Mills DA, Olympic Seafood, Amgen, Sanofi, and Pronova, none of which are related to the content of this manuscript. The other authors have no relevant financial relationships to disclose.

Funding Statement

This work was funded by the University of Oslo (Oslo, Norway), the National Advisory Unit on FH at OUH (Oslo, Norway), the Throne-Holst Foundation for Nutrition Research (Oslo, Norway), the South-Eastern Regional Health Authority (Oslo, Norway), the Academy of Finland (#315568 and #332564 to KO), the Jane and Aatos Erkko Foundation (to MJ), the Finnish Foundation for Cardiovascular Research (to MJ and KO), the Aarne Koskelo Foundation (to KO), and the Novo Nordisk Foundation (to KO). Wihuri Research Institute is maintained by the Jenny and Antti Wihuri Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Regional Committee for Research Ethics in South East Norway approved the study, and the study protocol was in accordance with the declaration of Helsinki.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Shared last authorship

  • Disclaimers: None.

Data Availability

Summary statistics are available in Supplementary Material, but individual level raw data will not be made available.

  • Abbreviations

    apoA-I
    apolipoprotein A-I
    apoB
    apolipoprotein B
    ASCVD
    atherosclerotic cardiovascular disease
    BMI
    body mass index
    BCAAs
    branched-chain amino acids
    CETP
    cholesteryl ester transfer protein
    DHA
    docosahexaenoic acid;
    FA
    fatty acids
    FH
    familial hypercholesterolemia
    HAE
    HDL-apoA-I exchange
    HDL
    high-density lipoprotein
    LA
    linoleic acid
    LCAT
    lecithin–cholesterol acyltransferase
    LDL
    low-density lipoprotein
    LDL aggr (PP)
    LDL aggregation (per particle)
    LDL aggr (TL)
    LDL aggregation (total load)
    LDLR
    LDL receptor
    MUFA
    monounsaturated fatty acids
    n3
    omega-3 fatty acids
    n6
    omega-6 fatty acids
    PC
    phosphatidylcholine
    PLTP
    phospholipid transfer protein
    PON1
    paraoxonase-1
    PUFA
    polyunsaturated fatty acids
    RCT
    reverse cholesterol transport
    SFA
    saturated fatty acids
    SM
    sphingomyelins
    VLDL
    very low-density lipoprotein
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted November 13, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Children with familial hypercholesterolemia display changes in LDL and HDL function: a cross-sectional study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Children with familial hypercholesterolemia display changes in LDL and HDL function: a cross-sectional study
    Jacob J. Christensen, Ingunn Narverud, Maija Ruuth, Martin Heier, Matti Jauhiainen, Stine M. Ulven, Martin P. Bogsrud, Petri T. Kovanen, Bente Halvorsen, Michael N. Oda, Cecilie Wium, Kjetil Retterstøl, Katariina Öörni, Kirsten B. Holven
    medRxiv 2020.11.11.20214247; doi: https://doi.org/10.1101/2020.11.11.20214247
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Children with familial hypercholesterolemia display changes in LDL and HDL function: a cross-sectional study
    Jacob J. Christensen, Ingunn Narverud, Maija Ruuth, Martin Heier, Matti Jauhiainen, Stine M. Ulven, Martin P. Bogsrud, Petri T. Kovanen, Bente Halvorsen, Michael N. Oda, Cecilie Wium, Kjetil Retterstøl, Katariina Öörni, Kirsten B. Holven
    medRxiv 2020.11.11.20214247; doi: https://doi.org/10.1101/2020.11.11.20214247

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (168)
    • Anesthesia (51)
    • Cardiovascular Medicine (452)
    • Dentistry and Oral Medicine (83)
    • Dermatology (55)
    • Emergency Medicine (158)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
    • Epidemiology (5268)
    • Forensic Medicine (3)
    • Gastroenterology (196)
    • Genetic and Genomic Medicine (759)
    • Geriatric Medicine (80)
    • Health Economics (213)
    • Health Informatics (699)
    • Health Policy (360)
    • Health Systems and Quality Improvement (224)
    • Hematology (99)
    • HIV/AIDS (164)
    • Infectious Diseases (except HIV/AIDS) (5889)
    • Intensive Care and Critical Care Medicine (363)
    • Medical Education (105)
    • Medical Ethics (25)
    • Nephrology (83)
    • Neurology (767)
    • Nursing (43)
    • Nutrition (131)
    • Obstetrics and Gynecology (143)
    • Occupational and Environmental Health (234)
    • Oncology (480)
    • Ophthalmology (152)
    • Orthopedics (39)
    • Otolaryngology (95)
    • Pain Medicine (39)
    • Palliative Medicine (20)
    • Pathology (141)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (136)
    • Primary Care Research (98)
    • Psychiatry and Clinical Psychology (864)
    • Public and Global Health (2021)
    • Radiology and Imaging (349)
    • Rehabilitation Medicine and Physical Therapy (158)
    • Respiratory Medicine (287)
    • Rheumatology (94)
    • Sexual and Reproductive Health (74)
    • Sports Medicine (77)
    • Surgery (110)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)